Prognosis of acute coronary syndrome complicated by stress hyperglycemia after percutaneous coronary intervention therapy

被引:1
|
作者
申健 [1 ]
李志明 [1 ]
何丽珍 [1 ]
刘锦光 [1 ]
申源生 [1 ]
罗晓丽 [1 ]
机构
[1] Department of Cardiology,Huizhou Municipal Central Hospital
关键词
stress hyperglycemia; acute coronary syndrome; prognosis;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
1002 ; 100201 ;
摘要
Background Several studies have reported an association of hyperglycemia with increased mortality and complications in hospital patients with acute coronary syndrome(ACS).However,the influence of stress hyperglycemia(SH)on the medium-and long-term prognoses in ACS patients has not yet been determined.Methods Random venous blood glucose levels were determined in 433 ACS patients and the patients were divided into two groups based on blood glucose results and disease histories.The 171 patients included in the experimental group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up and had fasting blood glucose levels of≥7.0 mmol/L and random blood glucose levels≥11.1 mmol/L.The 262 patients included in the control group had no history of diabetes,had no diabetes and/or glucose metabolism disorders during hospitalization and follow-up,and had fasting blood glucose levels<6.1 mmol/L and random blood glucose levels<7.8 mmol/L.Basic clinical information,coronary angiographic lesion characteristics,PCI success rate,complication rate,incidence and morbidity rate of cardiovascular events during the hospitalization period and 6 years of follow-up were compared between the two groups.Results There was no significant difference in age,gender or disease history between the two groups.The triglyceride levels and the left ventricular ejection fractions were significantly higher(P=0.00)and significantly lower(P=0.03)in the experimental group than in the control group,respectively.Both groups were subjected to coronary angiography and PCI.The PCI success rates of the two groups did not differ significantly(P=0.63).The experimental group had more type B2 lesions,but fewer type A lesions compared with the control group.The experimental group had significantly more stents implanted compared with the control group(P<0.05).The cardiovascular events were significantly increased(P=0.01)in the experimental group compared with the control group 1 year after discharge.The incidence of cardiovascular events did not differ significantly between the two groups 1-2 years after discharge.The event incidences were significantly higher(P=0.05)in the experimental group than in the control group at the end of follow-up.The experimental group was more prone to myocardial infarction and ischemic target vessel revascularization than the control group,but the control group was more prone to unstable stenocardia and heart failure than the experimental group.The psychogenic mortality of the two groups were similar.The interval and the overall mortality rates(P=0.054)of the two groups were also similar.Conclusions Patients with ACS complicated by SH were more likely to have cardiovascular events 1 year after PCI,whereas SH did not affect the mid-or long-term prognoses of these patients.SH is an independent risk factor for cardiovascular events.
引用
收藏
页码:243 / 251 +256
页数:10
相关论文
共 50 条
  • [41] Effect of Coronary Dominance on 2-Year Outcomes After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
    He, Chen
    Ma, Yuan-Liang
    Wang, Chuang-Shi
    Song, Ying
    Tang, Xiao-Fang
    Zhao, Xue-Yan
    Gao, Run-Lin
    Yang, Yue-Jin
    Xu, Bo
    Yuan, Jin-Qing
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 : 549 - 554
  • [42] Embolization after percutaneous coronary intervention in acute coronary syndrome Saphenous vein grafts versus native coronary arteries
    Karakyriou, M.
    Hadjimiltiades, S.
    Meditskou, S.
    Nenopoulou, E.
    Efthimiadis, G.
    Vogazianos, P.
    Karvounis, C.
    Styliadis, I.
    HERZ, 2015, 40 : 36 - 42
  • [43] The predictive value of plasma cystatin C for acute coronary syndrome treated with percutaneous coronary intervention
    Sun, Tong-Wen
    Xu, Qing-Yan
    Yao, Hai-Mu
    Zhang, Xiao-Juan
    Wu, Qiong
    Zhang, Jin-Ying
    Li, Ling
    Zhang, Yan-Zhou
    Kan, Quan-Cheng
    Guan, Fang-Xia
    Wang, Le-Xin
    HEART & LUNG, 2012, 41 (05): : 456 - 462
  • [44] Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data br
    Egorova, I. S.
    Vezikova, N. N.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2022, 18 (06) : 669 - 675
  • [45] Percutaneous coronary intervention for acute coronary syndrome in a patient with dextrocardia and situs inversus
    Qi, Wantao
    Wang, Zhiyong
    Hu, Sile
    ASIAN JOURNAL OF SURGERY, 2021, 44 (10) : 1318 - 1319
  • [46] Percutaneous Coronary Intervention in Acute Coronary Syndrome with Mild-to-Moderate Thrombocytopenia
    Ye, Yicong
    Hao, Yongchen
    Zhao, Xiliang
    Liu, Jun
    Yang, Na
    Smith Jr, Sidney C.
    Huo, Yong
    Fonarow, Gregg C.
    Ge, Junbo
    Morgan, Louise
    Sun, Zhaoqing
    Hu, Danqing
    Yang, Yiqian
    Ma, Chang-Sheng
    Zhao, Dong
    Han, Yaling
    Liu, Jing
    Zeng, Yong
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (03) : 218 - 229
  • [47] Clinical impact of noncontrast percutaneous coronary intervention in patients with acute coronary syndrome
    Higuchi, Satoshi
    Kabeya, Yusuke
    Nishina, Yoshio
    Miura, Yusuke
    Shibata, Shigeki
    Hata, Noritaka
    Suda, Tomoya
    Hirabuki, Kazukuni
    Hasegawa, Hiroshi
    Yoshino, Hideaki
    Matsuda, Takeaki
    JOURNAL OF MEDICAL INVESTIGATION, 2022, 69 (1-2) : 57 - 64
  • [48] Successful percutaneous coronary intervention for acute coronary syndrome in a patient with haemophilia B
    Koklu, Erkan
    Bayar, Nermin
    Yuksel, Isa Oner
    Esin, Murat
    Arslan, Sakir
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2015, 43 (04): : 385 - 388
  • [49] Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention
    Beth L. Nordstrom
    Jason C. Simeone
    Zhenxiang Zhao
    Cliff Molife
    Patrick L. McCollam
    Xin Ye
    Mark B. Effron
    American Journal of Cardiovascular Drugs, 2013, 13 : 263 - 271
  • [50] Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Ferrieres, Jean
    Bakhai, Ameet
    Iniguez, Andres
    Schmitt, Claude
    Sartral, Magali
    Belger, Mark
    Zeymer, Uwe
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (09) : 2193 - 2202